Search

Author/Creator Peipp, Matthias

1. An IgG3 switch variant of rituximab mediates enhanced complement‐dependent cytotoxicity against tumour cells with low CD20 expression levels. (7th January 2013)

Authors:
Rösner, Thies; Derer, Stefanie; Kellner, Christian; Dechant, Michael; Lohse, Stefan; Vidarsson, Gestur; Peipp, Matthias; Valerius, Thomas
Journal:
British journal of haematology
Issue:
Volume 161:Number 2(2013:Apr.)
Page Start:
282
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Bispecific antibodies enhance tumor-infiltrating T cell cytotoxicity against autologous HER-2-expressing high-grade ovarian tumors. Issue 6 (13th December 2019)

Authors:
Oberg, Hans-Heinrich; Janitschke, Lisa; Sulaj, Vjola; Weimer, Jörg; Gonnermann, Daniel; Hedemann, Nina; Arnold, Norbert; Kabelitz, Dieter; Peipp, Matthias; Bauerschlag, Dirk; Wesch, Daniela
Journal:
Journal of leukocyte biology
Issue:
Volume 107:Issue 6(2020)
Page Start:
1081
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Bispecific antibodies enhance tumor‐infiltrating T cell cytotoxicity against autologous HER‐2‐expressing high‐grade ovarian tumors. Issue 6 (13th December 2019)

Authors:
Oberg, Hans‐Heinrich; Janitschke, Lisa; Sulaj, Vjola; Weimer, Jörg; Gonnermann, Daniel; Hedemann, Nina; Arnold, Norbert; Kabelitz, Dieter; Peipp, Matthias; Bauerschlag, Dirk; Wesch, Daniela
Journal:
Journal of leukocyte biology
Issue:
Volume 107:Issue 6(2020)
Page Start:
1081
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody‐dependent cell‐mediated cytotoxicity and complement‐dependent cytotoxicity. (27th April 2017)

Authors:
Lohse, Stefan; Loew, Sebastian; Kretschmer, Anna; Jansen, J. H. Marco; Meyer, Saskia; ten Broeke, Toine; Rösner, Thies; Dechant, Michael; Derer, Stefanie; Klausz, Katja; Kellner, Christian; Schwanbeck, Ralf; French, Ruth R.; Tipton, Thomas R. W.; Cragg, Mark S.; Schewe, Denis M.; Peipp, Matthias;...
Journal:
British journal of haematology
Issue:
Volume 181:Number 3(2018)
Page Start:
413
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions. Issue 8 (18th June 2021)

Authors:
Baumann, Niklas; Rösner, Thies; Jansen, J. H. Marco; Chan, Chilam; Marie Eichholz, Klara; Klausz, Katja; Winterberg, Dorothee; Müller, Kristina; Humpe, Andreas; Burger, Renate; Peipp, Matthias; Schewe, Denis M.; Kellner, Christian; Leusen, Jeanette H. W.; Valerius, Thomas
Journal:
Cancer science
Issue:
Volume 112:Issue 8(2021)
Page Start:
3029
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30. (2nd January 2016)

Authors:
Kellner, Christian; Günther, Andreas; Humpe, Andreas; Repp, Roland; Klausz, Katja; Derer, Stefanie; Valerius, Thomas; Ritgen, Matthias; Brüggemann, Monika; van de Winkel, Jan GJ; Parren, Paul WHI; Kneba, Michael; Gramatzki, Martin; Peipp, Matthias
Journal:
Oncoimmunology
Issue:
Volume 5:Number 1(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. IgA EGFR antibodies mediate tumour killing in vivo. Issue 8 (5th August 2013)

Authors:
Boross, Peter; Lohse, Stefan; Nederend, Maaike; Jansen, Johannes Hendrik Marco; van Tetering, Geert; Dechant, Michael; Peipp, Matthias; Royle, Louise; Liew, Li Phing; Boon, Louis; van Rooijen, Nico; Bleeker, Wim K.; Parren, Paul W. H. I.; van de Winkel, Jan G. J.; Valerius, Thomas; Leusen, Jeanet...
Journal:
EMBO molecular medicine
Issue:
Volume 5:Issue 8(2013:Aug.)
Page Start:
1213
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. IMMU-39. EVALUATION OF CD317-TARGETING CAR T CELLS AS A NOVEL IMMUNOTHERAPEUTIC STRATEGY AGAINST GLIOBLASTOMA. (12th November 2021)

Authors:
Hänsch, Lena; Peipp, Matthias; Myburgh, Renier; Silginer, Manuela; Weiss, Tobias; Gramatzki, Dorothee; Vasella, Flavio; Manz, Markus; Weller, Michael; Roth, Patrick
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 6(2021)
Page Start:
vi101
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. NKp46‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats. (24th February 2023)

Authors:
Lipinski, Britta; Arras, Paul; Pekar, Lukas; Klewinghaus, Daniel; Boje, Ammelie Svea; Krah, Simon; Zimmermann, Jasmin; Klausz, Katja; Peipp, Matthias; Siegmund, Vanessa; Evers, Andreas; Zielonka, Stefan
Journal:
Protein science
Issue:
Volume 32:Number 3(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗